| First Author | Mambetsariev N | Year | 2016 |
| Journal | Sci Rep | Volume | 6 |
| Pages | 35349 | PubMed ID | 27752131 |
| Mgi Jnum | J:251796 | Mgi Id | MGI:6102284 |
| Doi | 10.1038/srep35349 | Citation | Mambetsariev N, et al. (2016) TRAF3 deficiency promotes metabolic reprogramming in B cells. Sci Rep 6:35349 |
| abstractText | The adaptor protein TNF receptor-associated factor 3 (TRAF3) is a critical regulator of B lymphocyte survival. B cell-specific TRAF3 deficiency results in enhanced viability and is associated with development of lymphoma and multiple myeloma. We show that TRAF3 deficiency led to induction of two proteins important for glucose metabolism, Glut1 and Hexokinase 2 (HXK2). This was associated with increased glucose uptake. In the absence of TRAF3, anaerobic glycolysis and oxidative phosphorylation were increased in B cells without changes in mitochondrial mass or reactive oxygen species. Chemical inhibition of glucose metabolism or glucose deprivation substantially attenuated the enhanced survival of TRAF3-deficient B cells, with a decrease in the pro-survival protein Mcl-1. Changes in Glut1 and Mcl-1 levels, glucose uptake and B cell number in the absence of TRAF3 were all dependent upon NF-kappaB inducing kinase (NIK). These results indicate that TRAF3 deficiency suffices to metabolically reprogram B cells, a finding that improves our understanding of the role of TRAF3 as a tumor suppressor, and suggests potential therapeutic strategies. |
